1.7 ML Wyost 70 MG/ML Injection
- RxCUI
- 2715393
- RxNorm name
- 1.7 ML Wyost 70 MG/ML Injection
- Display name
- 1.7 ML Wyost 70 MG/ML Injection
- Full name
- 1.7 ML Wyost 70 MG/ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:02
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761362 | Jubbonti | denosumab-bbdz | 351(k) Interchangeable | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WYOST | DENOSUMAB | Sandoz Inc | 69e4890d-5dd9-42a5-aa41-ce50635eaed7 | 2026-02-20 | Warnings, Adverse reactions | 2715393 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 69e4890d-5dd9-42a5-aa41-ce50635eaed7 | Wyost 120 MG in 1.7 ML Injection [PSN] · 1.7 ML denosumab-bbdz 70 MG/ML Injection [Wyost] [SBD] · 1.7 ML Wyost 70 MG/ML Injection [SY] · Wyost 120 MG per 1.7 ML Injection [SY] | 4 | 6 | These highlights do not include all the information needed to use WYOST ® safely and effectively. See full prescribing information for WYOST. WYOST ® (denosumab-bbdz) injection, for subcutaneous use Initial U.S. Approval: 2024 WYOST (denosumab-bbdz) is biosimilar* to XGEVA ® (denosumab). | 20260220 |